Aviron


Aviron is a biopharmaceutical company headquartered in Mountain View, California, focused on prevention of disease through innovative vaccine technologies. The company's product portfolio includes: FluMist, a live virus vaccine delivered as a nasal mist for the prevention of influenza; a live parainfluenza virus type 3 vaccine; a vaccine to prevent Epstein-Barr virus, and a cytomegalovirus vaccine.

Aviron is a biopharmaceutical company headquartered in Mountain View, California, focused on prevention of disease through innovative vaccine technologies. The company's product portfolio includes: FluMist, a live virus vaccine delivered as a nasal m...Show all

Company (Acquired)

Phone:

Fax:



Mountain View,
California, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Aviron $21.8M Dec 3, 2001
See all 14 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Aviron Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 5 investors
There is no Board of Directors data available for this company. Please select another tab.

Competitors

Company Status Description Investors

Iomai Corporation

Gaithersburg, Maryland, United States
AcquiredIomai Corporation is developing vaccines and immune system stimulants delivered through needle-free transcutaneous immunizationLogin to see details

Panacos Pharmaceuticals

Watertown, Massachusetts, United States
Alive / ActivePanacos is developing anti-infective products through discovery and development of small molecule oral drugs for the treatment of HIV and other major human viral diseases. Per the company, Panacos' proprietary discovery technologies are designed to combat resistance by focusing on novel targets in the virus life cycle, including virus maturation and virus fusion.Login to see details
See all 14 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)